Biocryst Pharmaceuticals (BCRX) Work In Process (2015 - 2017)

Biocryst Pharmaceuticals' Work In Process history runs 3 years deep, the most recent figure standing at $1.3 million for Q2 2017.

• Quarterly Work In Process fell 33.04% year-over-year to $1.3 million in Q2 2017, while the trailing twelve-month figure through Jun 2017 was $1.3 million (down 33.04% YoY) and the FY2016 annual result came in at $500000.0, down 68.98% from the prior year.
• Work In Process was $1.3 million for Q2 2017 at Biocryst Pharmaceuticals, up from $655000.0 in the prior quarter.
• Across five years, Work In Process topped out at $2.2 million in Q3 2016 and bottomed at $500000.0 in Q4 2016.
• A 3-year average of $1.5 million and a median of $1.6 million in 2015 frame the typical range for Work In Process.
• Annual changes were most pronounced in 2016 — Work In Process sank 68.98% — and 2017, when it tumbled 33.04%.
• Biocryst Pharmaceuticals' Work In Process stood at $1.6 million in 2015, then slumped by 68.98% to $500000.0 in 2016, then soared by 161.0% to $1.3 million in 2017.
• Business Quant data shows BCRX's Work In Process at $1.3 million in Q2 2017, $655000.0 in Q1 2017, and $500000.0 in Q4 2016.